leadf
logo-loader
viewAvacta Group PLC

BioIndustry Association marks 'golden age of biotech'

Dr Martin Turner who's head of policy and public affairs at the BioIndustry Association tells Proactive London it's a golden age of biotech currently with many more people wanting to get involved and invest in the sector. He says for newcomers to the space it's important they familiarise themselves with the clinical trial process as well as the different types of therapies and the science behind them. He says that as traditional sectors continue to suffer with the market disruption brought about by coronavirus, biopharma and healthcare is one of the few economic sectors to have largely escaped the global downturn.

Quick facts: Avacta Group PLC

Price: 129 GBX

AIM:AVCT
Market: AIM
Market Cap: £325.92 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Avacta Group PLC named herein, including the promotion by the Company of Avacta Group PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Integumen's Gerry Brandon outlines collaboration with Avacta for real-time...

Integumen PLC's (LON:SKIN) Gerry Brandon caught up with Proactive London's Andrew Scott after announcing a collaboration with Avacta PLC (LON:AVCT) to use their technology in a coronavirus (COVID-19) detection kit. He says they've signed a material transfer agreement to use recently-generated...

on 13/7/20

2 min read